Proteome shares rise on EU funding; Prostate marker could help surgery decisions;

> A team of researchers in Ireland have validated a prostate biomarker that could support accurate preoperative staging of prostate cancer, helping doctors make better treatment decisions. Abstract

> Astute Medical expects to launch its NephroCheck Test, a biomarker-based test for acute kidney injury in critically ill patients, in Europe this year. Press release

> Biomarker company Proteome Sciences' ($PRM.L) shares have risen on the news that Euro-HYP-1, the consortium of academic, clinical and industrial European partners that includes Proteome, has received an €11 million ($14.6 million) award for research into stroke. Article

> In non-small cell lung cancer patients treated with the targeted drug erlotinib, finding new lesions using 18F-FDG PET is a potential surrogate biomarker for survival. Abstract

> Researchers have shown the first signs that the Wnt signaling pathway may include a biomarker for scleroderma but also said that more research is needed. Press release

> A blood test based on ischemia-modified albumin is a potential diagnostic biomarker in diabetic ketosis. Abstract

> Serum biomarkers were predictive of higher frequencies of seizures in people with temporal lobe epilepsy. Abstract

> DNA methylation (the addition of small groups on DNA strands) may be a biomarker for schizophrenia. Abstract

> Restore Biodiagnostics has received a National Institutes of Health grant to develop a rapid point of care saliva test to assess stress levels, based on the stress biomarker cortisol. Press release

> NextGen Sciences Dx has filed for intellectual property on a combination of protein biomarkers with the potential for diagnosing changes in cognition for patients with early-stage dementia. Press release

> Protagen and the University of Tübingen are collaborating to develop multiplex assays for diagnosing autoimmune diseases and cancer. Article

> Taiwanese university National Cheng Kung University has signed a memorandum of understanding with Ohio State University College of Pharmacy to develop diagnostic markers and therapeutic agents for pancreatic cancer. Press release

> Finding the peptide megalin in the urine could mark the development and severity of diabetic nephropathy. Article

> HealthLinx is carrying out a study to support the South Korean submission of its biomarker-based ovarian cancer diagnostic test, OvPlex. Article

And Finally… David Alland of UMDNJ has received a tuberculosis biomarkers grant from the Bill & Melinda Gates Foundation's Grand Challenges in Global Health program. Article

Suggested Articles

By employing heart rate signals, physical activity and sleep quality, common Fitbit trackers may be able to predict the spread of the flu.

Nanox has raised $26 million to help fuel the development and commercialization of its Star Trek-inspired digital X-ray bed.

Oncology is clearly a major medical and societal issue, but one that sees too much focus from biopharmas at the expense of other killers.